Inoue H K, Kohga H, Hirato M, Sasaki T, Ishihara J, Shibazaki T, Ohye C, Andou Y
Department of Neurosurgery, Gunma University School of Medicine and Gamma Knife Center, Hidaka Hospital, Gunma, Japan.
Stereotact Funct Neurosurg. 1999;72 Suppl 1:125-31. doi: 10.1159/000056448.
The clinical outcome of 122 patients with pituitary adenomas treated by microsurgery and/or Gamma Knife radiosurgery (GKRS) was analyzed to evaluate patient selection criteria and the role of GKRS. Sixty-six resections were performed in 59 patients. All tumors were macroadenomas, except for 5 ACTH-producing adenomas. Twenty-four of the 31 hypersecreting adenomas showed normal serum hormone values after treatment. Postoperative complications were rhinorrhea, cranial nerve palsies, and a small thalamic infarct. GKRS was performed on 18 of the operated patients because of residual tumors, mostly in the cavernous sinus. Thirty-five of the 63 patients treated by GKRS were followed for more than 2 years. All adenomas except 2 were stable or had decreased in size. Eleven of 17 functioning adenomas showed normal serum hormone values after treatment. It is concluded that tumors that compress the optic pathway should be removed and that residual tumors in the cavernous sinus are good indications for radiosurgery.
分析了122例经显微手术和/或伽玛刀放射外科治疗(GKRS)的垂体腺瘤患者的临床结果,以评估患者选择标准和GKRS的作用。59例患者进行了66次切除术。除5例促肾上腺皮质激素分泌腺瘤外,所有肿瘤均为大腺瘤。31例分泌过多腺瘤中有24例治疗后血清激素值正常。术后并发症包括脑脊液鼻漏、颅神经麻痹和小的丘脑梗死。18例手术患者因残留肿瘤接受了GKRS治疗,残留肿瘤大多位于海绵窦。63例接受GKRS治疗的患者中有35例随访超过2年。除2例腺瘤外,所有腺瘤均稳定或缩小。17例功能性腺瘤中有11例治疗后血清激素值正常。结论是,压迫视路的肿瘤应予以切除,海绵窦内的残留肿瘤是放射外科治疗的良好适应证。